| Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico Y Santa-Ana-Tellez, AK Mantel-Teeuwisse, A Dreser, HGM Leufkens, ... PloS one 8 (10), e75550, 2013 | 147 | 2013 |
| Heterogeneous effects of health insurance on out-of-pocket expenditure on medicines in Mexico VJ Wirtz, Y Santa-Ana-Tellez, E Servan-Mori, L Avila-Burgos Value in Health 15 (5), 593-603, 2012 | 115 | 2012 |
| Analysing policy interventions to prohibit over‐the‐counter antibiotic sales in four Latin American countries VJ Wirtz, JJ Herrera‐Patino, Y Santa‐Ana‐Tellez, A Dreser, M Elseviers, ... Tropical Medicine & International Health 18 (6), 665-673, 2013 | 90 | 2013 |
| Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low-and middle-income countries O Galárraga, VJ Wirtz, A Figueroa-Lara, Y Santa-Ana-Tellez, I Coulibaly, ... Pharmacoeconomics 29, 579-599, 2011 | 67 | 2011 |
| Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in Mexico AL Sauceda-Valenzuela, VJ Wirtz, Y Santa-Ana-Téllez, ... BMC health services research 10, 1-11, 2010 | 48 | 2010 |
| Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions Y Santa-Ana-Tellez, AK Mantel-Teeuwisse, HGM Leufkens, VJ Wirtz Antimicrobial agents and chemotherapy 59 (1), 105-110, 2015 | 40 | 2015 |
| Estimating adherence based on prescription or dispensation information: impact on thresholds and outcomes. A real-world study with atrial fibrillation patients treated with … I Hurtado-Navarro, A García-Sempere, C Rodríguez-Bernal, ... Frontiers in Pharmacology 9, 417940, 2018 | 35 | 2018 |
| Opportunities and challenges for decentralized clinical trials: European regulators’ perspective AJ de Jong, TI van Rijssel, MGP Zuidgeest, GJMW van Thiel, S Askin, ... Clinical Pharmacology & Therapeutics 112 (2), 344-352, 2022 | 34 | 2022 |
| Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A … A García-Sempere, I Hurtado, D Bejarano-Quisoboni, C Rodríguez-Bernal, ... PLoS One 14 (2), e0211681, 2019 | 29 | 2019 |
| Financing HIV programming: how much should low-and middle-income countries and their donors pay? O Galárraga, VJ Wirtz, Y Santa-Ana-Tellez, EL Korenromp PloS one 8 (7), e67565, 2013 | 29 | 2013 |
| Costs of interventions for AIDS orphans and vulnerable children Y Santa‐Ana‐Tellez, LM DeMaria, O Galárraga Tropical Medicine & International Health 16 (11), 1417-1426, 2011 | 23 | 2011 |
| Factores asociados a la demanda de servicios para la atención del parto en México MÁ González-Block, AL Sauceda-Valenzuela, YS Ana-Téllez salud pública de méxico 52, 416-423, 2010 | 22 | 2010 |
| Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis CL Rodríguez-Bernal, A García-Sempere, I Hurtado, Y Santa-Ana, S Peiró, ... BMJ open 8 (12), e025102, 2018 | 17 | 2018 |
| Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America VJ Wirtz, Y Santa-Ana-Tellez, CH Trout, WA Kaplan Health policy and planning 27 (8), 638-648, 2012 | 17 | 2012 |
| Covid‐19 and the emerging regulatory guidance for ongoing clinical trials in the European Union AJ de Jong, Y Santa‐Ana‐Tellez, GJMW van Thiel, MGP Zuidgeest, ... Clinical Pharmacology & Therapeutics 109 (6), 1517-1527, 2021 | 16 | 2021 |
| Ethics review of decentralized clinical trials (DCTs): results of a mock ethics review TI van Rijssel, AJ de Jong, Y Santa-Ana-Tellez, M Boeckhout, ... Drug discovery today 27 (10), 103326, 2022 | 15 | 2022 |
| Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus Y Santa-Ana-Tellez, B Lagerwaard, AJ de Jong, H Gardarsdottir, ... Drug Discovery Today 28 (4), 103520, 2023 | 12 | 2023 |
| Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis Y Santa-Ana-Tellez, AK Mantel-Teeuwisse, HGM Leufkens, VJ Wirtz Health Policy and Planning 31 (9), 1291-1296, 2016 | 11 | 2016 |
| Data sources for drug utilization research in Latin American countries—A cross‐national study: DASDUR‐LATAM study LC Lopes, M Salas, CGS Osorio‐de‐Castro, LF Leal, SV Doubova, ... Pharmacoepidemiology and drug safety 31 (3), 343-352, 2022 | 10 | 2022 |
| Affordable, quality, long-term care and pharmacotherapy of chronic diseases: a framework for low and middle income countries VJ Wirtz, WA Kaplan, Y Santa-Ana-Tellez, RL Ridaura | 10 | 2011 |
Veronika J. WirtzBoston University School of Public HealthVerified email at bu.edu
